Naropin (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Naropin drug offered from Fresenius Kabi USA, LLC. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | ROPIVACAINE HYDROCHLORIDE |
| SUBSTANCE NAME: | ROPIVACAINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |
| ROUTE: | EPIDURAL; PERINEURAL |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-05-31 |
| END MARKETING DATE: | 0000-00-00 |
Naropin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Naropin from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.5(mg/mL) |
| START MARKETING DATE: | 2011-05-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-287_b7de3ae4-ecef-44b0-b20a-7b3a5926d2b9 |
| PRODUCT NDC: | 63323-287 |
| APPLICATION NUMBER: | NDA020533 |
Other ROPIVACAINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
